Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical and Experimental Medicine|February 25, 2009
Immunomodulation in the treatment of haematological malignanciesMichela Cesco-Gaspere, Emma Morris, Hans J StaussCancer Immunology, Immunotherapy : CII|February 5, 2005
BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodiesMichela Cesco-Gaspere, Federica Benvenuti, Oscar R BurroneFrontiers in Bioscience : a Journal and Virtual Library|January 10, 2002
Anti-idiotypic DNA vaccines for B-cell lymphoma therapyFederica Benvenuti, Michela Cesco-Gaspere, Oscar R BurroneJournal of Molecular Biology|September 25, 2002
Efficient folding of the FcepsilonRI alpha-chain membrane-proximal domain D2 depends on the presence of the N-terminal domain D1Luca Vangelista, Michela Cesco-Gaspere, Doriano Lamba, et al.Protein Engineering|February 14, 2002
A minimal receptor-Ig chimera of human FcepsilonRI alpha-chain efficiently binds secretory and membrane IgELuca Vangelista, Michela Cesco-Gaspere, Roberto Lorenzi, et al.Frontiers in Oncology|November 20, 2012
Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulinsAlejandro López-Requena, Oscar R Burrone, Michela Cesco-GaspereExpert Opinion on Biological Therapy|August 21, 2007
T-cell receptor gene therapy for cancer: the progress to date and future objectivesSharyn Thomas, Daniel P Hart, Shao-An Xue, et al.Molecular Immunology|February 24, 2007
Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent mannerAlejandro López-Requena, Marco Bestagno, Cristina Mateo de Acosta, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cellsSharyn Thomas, Shao-An Xue, Michela Cesco-Gaspere, et al.Blood Cells, Molecules & Diseases|September 15, 2007
WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cellsHans J Stauss, Sharyn Thomas, Michela Cesco-Gaspere, et al.Pageof 2